Zobrazeno 1 - 3
of 3
pro vyhledávání: '"Nathalie, Beranger"'
Autor:
Catherine Thieblemont, Marjane Ertault, Patricia Franchi, Cédric de Bazelaire, Eric de Kerviler, Josette Brière, Nathalie Beranger, Chadi Al Nawakil, Pauline Brice, David Sibon
Publikováno v:
British Journal of Haematology. 153:191-198
Summary Around 20% of Hodgkin lymphoma (HL) patients are refractory to first-line therapy with ABVD (adriamycin–bleomycin–vinblastine–dacarbazine) or relapse after complete remission. Salvage regimens frequently have delayed courses or require
Autor:
Antoine Faure, Pierce Bareiss, Rachid El Behlgiti, Jean-Pierre Monassier, Francis Schneider, Nathalie Beranger, Olivier Morel, Marie-Odile Michotey, Laurent Jaquemin, Patrick Ohlmann, Gerald Roul
Publikováno v:
American Heart Journal. 152:1161-1167
Background The rise in cardiac troponin I after ST-elevation myocardial infarction treated by primary percutaneous coronary interventions (PCIs) is predictive of infarct size and left ventricular ejection fraction (LVEF). However, the comparative val
Autor:
David, Sibon, Marjane, Ertault, Chadi, Al Nawakil, Cédric, de Bazelaire, Patricia, Franchi, Josette, Brière, Eric, de Kerviler, Nathalie, Beranger, Catherine, Thieblemont, Pauline, Brice
Publikováno v:
British journal of haematology. 153(2)
Around 20% of Hodgkin lymphoma (HL) patients are refractory to first-line therapy with ABVD (adriamycin-bleomycin-vinblastine-dacarbazine) or relapse after complete remission. Salvage regimens frequently have delayed courses or require dose-reduction